2024-2025 Regular Session • New Jersey Legislature
S3561
Legislative Summary
Permits procurement of medical countermeasures, products, and therapeutics.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
9/12/2024
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Senate
12/9/2024
Reported from Senate Committee, 2nd Reading
Senate
2/25/2025
Passed by the Senate (38-0)
Senate
2/25/2025
Received in the Assembly, Referred to Assembly Appropriations Committee
General Assembly
Roll Call Votes
Senate Floor: Third Reading - Final Passage
2/25/2025
38
Yea
0
Nay
2
Not Voting
0
Absent
Result: PASSED
Senate Health, Human Services and Senior Citizens Committee: Reported Favorably
12/9/2024
8
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Engrossed(2/25/2025)
Chamber
General Assembly
Committee
Appropriations(General Assembly)
